Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewa D Marczak

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Pharmacogenetics and Genomics|June 7, 2012
Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humansEwa D Marczak, Jacqui Marzec, Darryl C Zeldin, et al.
Journal of Medicinal Chemistry|August 6, 2008
Further studies on lead compounds containing the opioid pharmacophore Dmt-TicGianfranco Balboni, Stella Fiorini, Anna Baldisserotto, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffoldsSteven Ballet, Ewa D Marczak, Debby Feytens, et al.
Bioorganic & Medicinal Chemistry|January 8, 2008
Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502)Severo Salvadori, Stella Fiorini, Claudio Trapella, et al.
European Journal of Medicinal Chemistry|January 11, 2011
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-TicGianfranco Balboni, Severo Salvadori, Ewa D Marczak, et al.
Journal of Medicinal Chemistry|March 4, 2008
Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imagingEun Kyoung Ryu, Zhanhong Wu, Kai Chen, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Conformationally constrained opioid ligands: the Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffoldSteven Ballet, Debby Feytens, Rien De Wachter, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Pharmacogenetics and Genomics|June 7, 2012
Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humansEwa D Marczak, Jacqui Marzec, Darryl C Zeldin, et al.
Journal of Medicinal Chemistry|August 6, 2008
Further studies on lead compounds containing the opioid pharmacophore Dmt-TicGianfranco Balboni, Stella Fiorini, Anna Baldisserotto, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffoldsSteven Ballet, Ewa D Marczak, Debby Feytens, et al.
Bioorganic & Medicinal Chemistry|January 8, 2008
Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502)Severo Salvadori, Stella Fiorini, Claudio Trapella, et al.
European Journal of Medicinal Chemistry|January 11, 2011
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-TicGianfranco Balboni, Severo Salvadori, Ewa D Marczak, et al.
Journal of Medicinal Chemistry|March 4, 2008
Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imagingEun Kyoung Ryu, Zhanhong Wu, Kai Chen, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Conformationally constrained opioid ligands: the Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffoldSteven Ballet, Debby Feytens, Rien De Wachter, et al.
Pageof 2